Synopsis: Akzo Nobel India, Nephrocare Health Services, and SG Finserve came into focus after bulk deals worth ₹1,522.09 crore were executed on December 17, 2025, highlighting strong institutional, promoter and individual investor activity.
Three small-cap stocks are in focus today after large bulk deals worth Rs. 1,522.09 crore were executed in the market. These transactions involved significant stake changes by promoters and institutional investors, indicating strong interest and possible strategic shifts. Bulk deals of this size often attract investor attention as they can signal confidence, restructuring, or changing outlooks for the companies involved.
Here are a few bulk deals that took place on December 17, 2025.
Akzo Nobel India Limited
With a market capitalization of Rs. 14,319.47 crore, the shares of Akzo Nobel India Limited were currently trading at Rs. 3,144.35 per equity share, rising nearly 0.38 percent from its previous day’s close price of Rs. 3,132.45.
On 17 December 2025, Akzo Nobel India Limited saw a major promoter stake sale, with its promoter Imperial Chemical Industries selling 40,97,025 shares, representing an 8.99 percent equity stake. The shares were sold at Rs. 3,163.5 per share, generating proceeds of over Rs. 1,296.09 crore. Prior to this transaction, the promoters held a 69.76 percent stake in the company as of September 2025.
On the same day, Goldman Sachs Funds, Goldman Sachs India Equity Portfolio purchased 3,35,465 shares of Akzo Nobel India at a price of Rs. 3,150 per share, amounting to a total investment value of approximately Rs. 105.67 crore, reflecting continued institutional investor interest in the company.
Akzo Nobel India Limited is engaged in manufacturing and selling decorative paints and performance coatings under brands like Dulux. The company provides protective solutions for homes, industries, and infrastructure across India.
Nephrocare Health Services Limited
With a market capitalization of Rs. 4,718.52 crore, the shares of Nephrocare Health Services Limited were currently trading at Rs. 470.25 per equity share, down nearly 0.29 percent from its previous day’s close price of Rs. 471.60.
Nephrocare Health Services saw strong investor interest with two major fund purchases. Polar Capital Funds Plc, through its Healthcare Opportunities Fund, acquired 34,27,866 shares, representing a 3.41 percent stake, for Rs. 165.14 crore at Rs. 481.77 per share.
In addition, Poonawalla Vision Fund I purchased 6,10,000 shares, equivalent to a 0.6 percent stake, for Rs. 29.89 crore at Rs. 490.05 per share, reflecting confidence from leading institutional investors.
Nephrocare Health Services Limited is engaged in operating dialysis centers and providing renal care services. The company manages kidney treatment facilities, offering hemodialysis and related healthcare support to patients nationwide.
SG Finserve Limited
With a market capitalization of Rs. 2,268.78 crore, the shares of SG Finserve Limited were currently trading at Rs. 405.90 per equity share, rising nearly 1.48 percent from its previous day’s close price of Rs. 400.
SG Finserve witnessed two promoter bulk deals on 17 December 2025. S Gupta Holding Private Limited first acquired 3 lakh shares at an average price of Rs. 399.98, investing about Rs. 12 crore.
In another bulk deal, the promoter purchased 4.75 lakh shares at Rs. 399.41 per share, amounting to Rs. 18.97 crore and representing a 0.84 percent equity stake. Overall, S Gupta Holding acquired a total of 7.75 lakh shares for a combined value of approximately Rs. 30.97 crore.
SG Finserve Limited is a non-banking financial company focused on providing supply chain and business financing solutions. The company supports small and medium enterprises by offering structured lending, working capital support, and credit solutions to improve cash flows and business efficiency.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post 3 Smallcap stocks in focus after shares worth ₹1,522 Cr exchange hands via bulk deals appeared first on Trade Brains.